研究開発におけるマルチフィジックスシミュレーションの具体例
マルチフィジックスモデリングとシミュレーションは, 産業界や学術界のさまざまな分野でイノベーションを推進しています. そのことは, 毎年 COMSOL Conference でエンジニア, 研究者, 科学者が発表する技術論文やポスターで紹介される数多くの活用事例からも明らかです. 以下にまとめられた最近の講演論文集から新たなアイデアやヒントを得たり, クイック検索ツールを使用して特定の発表を検索したり, アプリケーション分野, カンファレンスの開催年や開催地で絞り込んだりできます.
COMSOL Conference 2026 論文集を見る
Introduction: Keratin protein biomaterials (KTN) are used in various tissue engineering applications including liquid infusions and gel implants. Random movement of molecular species is characterized by Fick’s laws of diffusion (and velocity-dependent convection) with the ... 詳細を見る
In his seminal work, “A Chemical Basis for Morphogenesis,” Alan Turing proposed a mechanism for pattern formation in nature. Turing patterns occur in a broad range of natural systems, from desert vegetation to animal markings. Turing mechanisms have also been implicated in processes ... 詳細を見る
Cancer cells have an increased sensitivity to heat compared to healthy cells; at 42°C cancer cells are destroyed while normal cells can survive up to 47°C. Thus hyperthermia-based approaches that target specific spatial locations and simultaneously provide controlled thermal exposure ... 詳細を見る
The DOE BETO consortium "ChemCatBio" has developed a packed bed catalyst for use in a Catalytic Fast Pyrolysis (CFP) process for producing biofuels and chemicals from lignocellulosic biomass. Another BETO consortium known as "CCPC" (Consortium for Computational Physics and Chemistry) is ... 詳細を見る
The setup of the problem: To develop a mathematical model of cerebral cortical folding development, half-hemisphere geometry is used and the outer layer (gray matter) is allowed to move inward under the effect of both physical and biochemical factors. The model is time-dependent, ... 詳細を見る
Pancreatic cancer is one of the deadliest cancers, with a 7% survival rate at five years from diagnosis. The limited number of treatment options for patients who are diagnosed with late-stage disease is a major contributor to this problem. Therapeutic modalities such as radiofrequency ... 詳細を見る
Introduction: Discovering therapeutic drugs that target renal disease is a challenge due to the adverse effects not detected until late in drug development [1]. Preclinical drug studies in animals and static human cell cultures fail to characterize <em>in vivo</em> renal ... 詳細を見る
Microencapsulation-based drug delivery has paved the way for the next generation of drug carrier systems that can deliver a therapeutic agent in a programmable fashion. In this method, therapeutic agent is encapsulated within a microparticle and delivered through hypodermic needles to ... 詳細を見る
